Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04744935 · ClinicalTrials.gov registry record · NA
Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma
A NA study of Basal Cell Carcinoma and Superficial Basal Cell Carcinoma, sponsored by Christopher Zachary.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04744935: Recruiting NA study of Basal Cell Carcinoma and Superficial Basal Cell Carcinoma, sponsored by Christopher Zachary.
NCT04744935 is a NA study of Basal Cell Carcinoma and Superficial Basal Cell Carcinoma that is actively recruiting participants, run by Christopher Zachary. The registered enrollment target is 40 participants, below the 103-participant average among 24 other Basal Cell Carcinoma trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04744935, a NA study of Basal Cell Carcinoma and Superficial Basal Cell Carcinoma, is actively recruiting participants, sponsored by Christopher Zachary.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Optical coherence tomography guided laser treatment of basal cell carcinoma
Primary Outcome
Those whose lesion is not in a cosmetically sensitive area will undergo a skin biopsy for histological confirmation of OCT results.
Conditions Studied
Interventions
- DEVICE 1064 nm long-pulse Nd:YAG laser
Study Locations (1)
California
- UCI Health Gottschalk Medical Plaza - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-01-13 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What NCT04744935 shows while recruiting
NCT04744935 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 103-participant average among 24 other Basal Cell Carcinoma trials with a reported enrollment target (61% lower).
The record links to 3 conditions, with Basal Cell Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which 1064 nm long-pulse Nd:YAG laser is the first listed.
NCT04744935 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04744935 about?
NCT04744935 is a clinical study titled "Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma". Optical coherence tomography guided laser treatment of basal cell carcinoma
What is the current status of trial NCT04744935?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2021-01-13. Estimated completion is 2025-12-31.
What conditions does trial NCT04744935 study?
This clinical trial studies the following conditions: Basal Cell Carcinoma, Superficial Basal Cell Carcinoma, Nodular Basal Cell Carcinoma.
What interventions are being tested in trial NCT04744935?
The interventions under investigation include: 1064 nm long-pulse Nd:YAG laser (DEVICE).
Who is sponsoring clinical trial NCT04744935?
This trial is sponsored by Christopher Zachary, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04744935 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Basal Cell Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04744935's enrollment target sits among peer trials
40 14th of 24 higher than 10 of 24 other Basal Cell Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Basal Cell Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy
RECRUITING · NA
-
Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas
RECRUITING · NA
-
Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery
COMPLETED · NA
-
Video-Based Treatment Options for Basal Cell Carcinoma
COMPLETED · NA
-
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
RECRUITING · Phase 2
-
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI